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Abstract
Background: According to current classification systems, patients with major depressive disorder (MDD) may have
very different combinations of symptoms. This symptomatic diversity hinders the progress of research into the
causal mechanisms and treatment allocation. Theoretically founded subtypes of depression such as atypical,
psychotic, and melancholic depression have limited clinical applicability. Data-driven analyses of symptom
dimensions or subtypes of depression are scarce. In this systematic review, we examine the evidence for the
existence of data-driven symptomatic subtypes of depression.
Methods: We undertook a systematic literature search of MEDLINE, PsycINFO and Embase in May 2012. We
included studies analyzing the depression criteria of the Diagnostic and Statistical Manual of Mental Disorders, fourth
edition (DSM-IV) of adults with MDD in latent variable analyses.
Results: In total, 1176 articles were retrieved, of which 20 satisfied the inclusion criteria. These reports described a
total of 34 latent variable analyses: 6 confirmatory factor analyses, 6 exploratory factor analyses, 12 principal
component analyses, and 10 latent class analyses. The latent class techniques distinguished 2 to 5 classes, which
mainly reflected subgroups with different overall severity: 62 of 71 significant differences on symptom level were
congruent with a latent class solution reflecting severity. The latent class techniques did not consistently identify
specific symptom clusters. Latent factor techniques mostly found a factor explaining the variance in the symptoms
depressed mood and interest loss (11 of 13 analyses), often complemented by psychomotor retardation or fatigue
(8 of 11 analyses). However, differences in found factors and classes were substantial.
Conclusions: The studies performed to date do not provide conclusive evidence for the existence of depressive
symptom dimensions or symptomatic subtypes. The wide diversity of identified factors and classes might result
either from the absence of patterns to be found, or from the theoretical and modeling choices preceding analysis.
Keywords: Major depressive disorder, subtypes, depressive symptoms, latent factor analyses, latent class analyses
Background
M a j o rd e p r e s s i v ed i s o r d e r( M D D )i so n eo ft h em o s t
important challenges in global mental health [1,2]. In
research, a continuing challenge is the diversity in the
symptoms and pathophysiology of patients classified as
having the disorder. MDD patients vary considerably in
clinical presentation, course, treatment response, genetics
and neurobiology [3-7]. One explanation for this diversity
is that MDD has a polythetic definition; that is, a patient
needs to satisfy some but not all symptoms. For the
diagnosis at least five of nine symptoms including at least
one of the two core symptoms must be present [8]. It fol-
lows that there are 227 possible combinations of symp-
toms leading to this diagnosis. This is such a wide array of
possibilities that two patients classified as having MDD
might have only a single symptom in common. This diver-
sity raises the question whether it makes sense for the pur-
poses of comparisons in research to consider all the people
who qualify for the diagnosis of MDD as having a single
disorder.
To overcome the problem of symptom diversity, several
attempts have been made to specify more homogenous
subgroups within MDD. Subtypes have been proposed
based on specific combinations of symptoms (for example,
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sonal affective disorder, postpartum, early versus late in
life), course (single, recurrent, chronic), or severity [6].
Most subtyping schemes are based on pattern recognition
and ordering using distinctions observed in clinical prac-
tice. For instance, 11 subtypes of MDD were proposed in
the Research Diagnostic Criteria (RDC), the forerunner of
the current Diagnostic and Statistical Manual of Mental
Disorders (DSM), based on combinations of clinical char-
acteristics, follow-up patterns, and findings from family
studies [9-11]. However, the value of such distinctions has
been called into question by the disappointing results of
attempts to use these and subsequent subtyping distinc-
tions in clinical practice [6,12,13].
A different approach to discern useful subtypes with
similar symptom profiles would be one that is data-driven;
that is, which uses any of several statistical techniques to
recognize patterns in reported symptoms of a heteroge-
neous group of subjects. These kinds of models have in
common the fact that they reduce a large number of data
from individuals to smaller numbers of latent variables
based on similarity. Two dominant types of latent variable
models are latent factor models and latent class models
[14]. Latent factor models, such as exploratory factor ana-
lysis (EFA), reduce originally correlated variables to fewer
latent factors (which might be specified as either corre-
lated or uncorrelated) based on the correlations between
the original variables [15,16]. By contrast, latent class mod-
els, such as cluster analysis (CA) and latent class analysis
(LCA) cluster individuals rather than variables into rela-
tively homogeneous subgroups. These subgroups are
based on measures of similarity between each pair of indi-
viduals summed across all the variables considered in the
analysis [17]. As both types of models are designed to dis-
cover structure in the absence of pre-existing hypotheses
about subtypes, they provide useful approaches for exam-
ining heterogeneity based on distinctions that are not
known beforehand [14].
Both latent factor and latent class models have been
used to study the possible existence of useful MDD sub-
types. However, findings in patients with MDD have not
been systematically reviewed and thus the overall out-
come is currently unclear. One of the questions, for
instance, is whether a two-factor model applies to
patients with MDD, as has been repeatedly found in
patients with somatic illnesses. In somatically ill
patients, latent factor analyses identified two main
dimensions of depressive symptoms: one factor consist-
ing of depressed mood, loss of interest, worthlessness,
concentration problems and suicidality, and a second
factor consisting of fatigue, appetite, sleep, and psycho-
motor disturbances [18,19]. The first set of symptoms is
typically referred to as ‘cognitive’ or ‘cognitive/affective’,
whereas the second set is typically referred to as
‘somatic’ or ‘somatic/affective’; however, whether a cog-
nitive and somatic symptom dimension is generalizable
to patients with MDD or is limited to patients with
somatic illnesses and comorbid depressive complaints is
unknown. Systematic reviews or meta-analyses of studies
empirically investigating the depressive symptom profiles
of patients with MDD have not yet been performed.
In search of data-driven subtypes of MDD, we per-
formed a systematic review of published studies that used
these latent variable models to distinguish symptomatic
subgroups or symptom dimensions for patients with
MDD. Our main question was whether those studies iden-
tify consistent subtypes or symptom dimensions. Second,
we evaluated whether the characteristic symptoms of
empirically derived subtypes resemble the descriptions of
current specifiers as melancholic and atypical [8]. Third,
we studied whether latent factor analyses in patients with
depression reveals a cognitive and somatic symptom
dimension, as has been found in patients with somatic
illnesses.
Methods
Search strategy
Studies were eligible for inclusion if they examined the
existence of MDD subtypes by means of a latent variable
analysis of depressive symptoms in patients with MDD.
We searched three electronic databases MEDLINE
(PubMed), Embase and PsycINFO for studies up to May
2012. We used the keywords ‘major depressive disorder’
and several synonyms for depressive subtype, symptom
profile or symptom cluster (for full search strings, see
Additional file 1). Many terms were used in the search,
and were tested repeatedly for their success in finding
relevant papers, based on our discovery of considerable
variation in terminology across relevant articles. We used
the database filters to exclude animal studies and studies
with children. We did not use language restrictions.
Retrieved articles were supplemented by studies cited in
the reference lists of included studies plus a limited num-
ber of articles we found by hand searching.
Inclusion criteria
An article was eligible if it presented original data. As our
primary interest was adult patients with MDD, we
required that at least 75% of the studied subjects had to
satisfy the criteria for MDD. We did not use a stricter cri-
terion of 100% patients with MDD, because for reasons
of completeness, we did not want to exclude studies with
a minor percentage of patients with minor depression,
adjustment disorder, or dysthymia. We included studies
classifying patients using the criteria of the RDC, DSM
(III or later versions), International Classification of Dis-
eases (ICD; 9 or 10), and Geriatric Mental State-Auto-
mated Geriatric Examination for Computer Assisted
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Page 2 of 12Taxonomy (GMS-AGECAT) systems, based on the fact
that the core symptoms of MDD in these different systems
have a great deal of overlap [9,20-25]. To limit the diver-
sity in the patient group, we excluded studies focusing on
somatically ill patients with comorbid MDD. We selected
all studies analyzing the existence of symptomatic sub-
types by means of a latent variable statistical method. We
were interested in all statistical methods capable of finding
symptom dimensions or latent classes in the depressive
symptoms. With regard to those symptoms, we organized
results by the nine Criterion A symptoms of depression in
the DSM-IV text revision, but with dichotomous distinc-
tions made for the three compound psychophysiological
symptoms in that diagnostic system (s3 (appetite/weight
disturbance), s4 (sleep disturbance) and s5 (psychomotor
disturbance)). These dichotomous distinctions (for exam-
ple, between insomnia and hypersomnia) might have value
in distinguishing subtypes [4] such as the previously sug-
gested subtypes of ‘typical’ and ‘atypical’ depression [8].
Studies were included in our review if they performed a
latent variable analysis on at least 6 of the 12 resulting dis-
aggregated symptomatic criteria for MDD.
Data extraction
The database search described above resulted in 1,135
articles. Analysis of the reference lists of included articles
provided another 29 relevant titles. Hand searching identi-
fied an additional 12 articles, giving a total of 1,176 unique
titles. Subsequently, two independent raters (HMvL and
PdJ reviewed the first half of articles,  = 0.70; HMvL and
RAS reviewed the second half of articles,  = 0.80)
reviewed the titles and abstracts of the identified studies to
exclude any studies clearly not satisfying the inclusion cri-
teria. If one (or both) of the reviewers assessed the title
and abstract as possibly relevant, this article continued to
be included in the review process. After this procedure, 93
studies remained included. We assessed the full text of all
these 93 articles, and excluded 73 of them based on this
review. In the end, 20 articles satisfied the inclusion cri-
teria (see Additional file 2), containing 34 latent variable
analyses in total (Figure 1).
Data analysis
The 34 analyses were examined as follows. First, we
extracted the study characteristics from the papers, and
in some cases obtained supplementary information from
the authors. Second, we examined all the different ques-
tionnaires used in the measurement of depressive symp-
toms (which included the Hamilton Rating Scale for
Depression (HRSD), the Beck Depression Inventory
(BDI), the Montgomery and Åsberg Depression Rating
Scale (MADRS), the Inventory for Depressive Symptoma-
tology (IDS), and the Brief Psychiatric Rating Scale
(BPRS)). Using the original questionnaires, we determined
which items of the different questionnaires corresponded
to the 12 disaggregated depressive symptoms [26-34]. We
then compared the results of the individual latent variable
techniques. In the case of the latent factor techniques, we
extracted the factors and the loadings of the 12 disaggre-
gated symptoms on these factors. In the case of the latent
class techniques, we extracted the reported latent classes
and the differences in scores of the 12 symptoms in each
class. The diversity in the questionnaires used precluded
the performance of a mega-analysis or meta-analysis.
Results
Literature search
The 34 analyses in the 20 articles satisfying the inclusion
criteria included 24 analyses that concerned the investiga-
tion of symptom dimensions by means of factor analyses
(n = 12) [35-39] or principal component analyses (n = 12)
[40-45], and 10 that concerned latent class analyses group-
ing a large number of individuals with depression into a
smaller number of patient subgroups [42,45-53]. No ana-
lyses combined a latent factor approach with a LCA even
though statistical techniques that allow this to be carried
out do exist [14]. The total number of patients with
depression was 7684. Samples included both men (38%)
and women (62%), and both inpatients and outpatients.
Overall, 96.6% of the study subjects satisfied the criteria
for MDD. A small minority (3.4%) of patients has been
given other diagnoses such as minor depressive disorder
or adjustment disorder, which were found in 7 of 20 arti-
cles (see Additional file 3, Table S1 and Table S2).
Measurement of depressive symptoms
In total, 11 different questionnaires (15 if we take into
account the different versions of the HRSD, SCL, and IDS)
were used to measure depressive symptoms in the 20
studies, whereas questionnaires measuring all 12 disaggre-
gated symptoms were rare (3 of 11, which were the
IDS; the SADS, Schedule for Affective Disorders and
Schizophrenia; and the Structured Clinical Interview for
DSM (SCID)). In particular, few questionnaires measured
both directions of the so-called somatic symptoms (s3 to
s6). For instance, data on appetite/weight gain (s3b) and
hypersomnia (s4b) were lacking in the majority of analyses.
Overall, of the 34 latent variable analyses, only 6 analyses
included all 12 disaggregated depressive symptoms. In
general, substantially different questions were used to
measure the same symptoms. These differences were espe-
cially marked for symptoms of feeling worthless or guilty
(s7) and having diminished ability to think or concentrate,
or increased indecisiveness (s8). Answer categories were
ordinal in 15 studies, binary in 3 studies (yes/no dichoto-
mized), and mixed in 2 studies.
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The 10 studies aimed at clustering patients based on
symptom similarity comprised a total of 3,270 patients,
with a mean of 327 patients analyzed per study (range 80
to 818). To visualize the effect of severity on class assign-
ment, we sorted the original identified classes per study on
overall severity. Therefore, we used the overall score of the
class on each complete questionnaire, with class (a) being
the most severe class of the study, class (b) being less
severe than (a) and so on (see Additional file 3, Table S3).
In total, there were 71 significant differences in symptom
scores between classes. Notably, 62 of the 71 significant
differences were related to class severity; that is, the overall
most severe class scored higher on the symptom than the
overall less severe class (Figure 2). This is in line with the
idea that these statistical techniques are specifically able to
separate more severe classes from less severe classes [14].
This pattern was especially clear in four of these studies
[45-48]. Only nine significant differences deviated from
this result [49,53] (Figure 3); all nine of these exceptions
concerned so-called somatic depressive symptoms, and
were present in latent class analyses of the two largest
samples of patients (n = 569 and n = 818), in which
patients in a less severe class scored higher than patients
in a more severe class for fatigue (s6), weight (s3), and
sleep disturbances (s4).
Figure 1 Flow chart of the review.
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Our search yielded 24 analyses aimed at discovering
dimensions of depressive symptoms. In total, there were
12 factor analyses and 12 principal component analyses
(PCA) from 12 studies (some studies performed different
analyses on the same patient sample). The factor analysis
studies concerned six exploratory factor analyses (EFA)
and six confirmatory factor analyses (CFA). The 12 factor
analyses were performed on larger studies, with a mean of
562 patients per study (range 96 to 1049, total n = 3369).
The 12 PCA concerned on average 174 patients (range 60
to 400, total n = 1045).
Confirmatory factor analyses
In two studies, CFA was used to test how well a single fac-
tor explained the variance in depressive symptoms [35,36]
(Table 1). The measures for model fit (Confirmatory Fit
Index, Tucker-Lewis Index, and Root Mean Square Error
of Approximation) showed that a single factor explained
about 50% of variance in depressive symptoms.
Exploratory factor and principal component analyses
Nine studies exploratorively analyzed the dimensions
underlying items of single questionnaires by means of
PCA and EFA. The resulting factors of the 10 PCA and 3
EFA differed considerably (Figure 4). First, the number of
derived factors varied from 2 to 7 (mean 3.5) explaining
between 36.8% and 79.3% of total variance (mean 55%).
Second, the item content of the identified factors varied
substantially. Concerning the cognitive symptoms (s1, s2,
s7, s8, s9) of patients with depression, 10 of 13 analyses
included all 5 cognitive symptoms, but of those 10, there
was not a single study in which all 5 cognitive symptoms
loaded on the same factor. In 3 of the 10 studies, 4 of 5
cognitive symptoms loaded on the same factor [39,41,45],
and in another 4 studies, 3 of the 5 cognitive symptoms
loaded on the same factor [38,43,44]. Only one study had
a factor on which four cognitive symptoms and no somatic
symptoms loaded [39]; at least one somatic symptom
loaded on the remaining six factors with three or more
cognitive symptoms.
With regard to the somatic symptoms (s3 to s6), 8 of 13
studies measured the 4 somatic symptoms of depression,
Figure 2 Latent class analyses.
Figure 3 General results from latent class analyses. Abbreviations:
tot., total significant differences in scores on disaggregated symptoms;
exc., exceptions on ordering based on severity.
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tite/weight, sleep, and psychomotor disturbance included,
and none of these 8 studies had a common factor on
which all 4, or 3 of the 4, somatic symptoms loaded. In 7
out of 8 analyses, at least one factor was identified that
explained the variance of 2 of the 4 somatic symptoms
[39-41,44,45], and the total number of factors with 2
somatic symptoms was 10, describing the variance of 6
Table 1 Confirmatory factor analyses.
Author Number of factors Items in analysis Explained variance TLI CFI RMSEA Factor correlation
Uher [12] 1 MADRS 0.57 0.99 0.97 0.10 NA
1 HRSD-17 0.36 0.93 0.87 0.09 NA
1 HRSD-6* 0.48 0.99 0.98 0.07 NA
1 BDI 0.48 0.97 0.88 0.10 NA
1 All 48 items 0.45 0.90 0.63 0.17 NA
Lux [35] 1 9 MDD symptoms - 0.97 0.96 0.07 NA
2 9 MDD symptoms - 0.97 0.97 0.06 0.83
Abbreviations: BDI, Beck Depression Inventory; CFI, Confirmatory Fit Index; HRSD, Hamilton Rating Scale for Depression; MADRS, Montgomery and Åsberg
Depression Rating Scale; MDD, major depressive disorder; NA, not applicable; * HRSD-6 contains 6 items out of the HRSD-17 (items 1,2,7,8,10,13) corresponding
to depressive symptoms 1,2,5b,6,7; - not recorded.
Figure 4 Principal component and exploratory factor analyses.
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with 2 somatic symptoms, 5 also incorporated one or
more cognitive symptoms [37,39,40,44,45].
The most consistent finding was that the 2 core symp-
toms of depression (sadness and loss of interest; s1 and
s2), loaded on one single factor in 11 out of 13 analyses
[37-41,43-45]. In 9 of these 11 analyses, s1 and s2 loaded
on factor 1, which was the factor explaining most of the
variance. Psychomotor retardation and/or fatigue (s5b
and s6) also loaded on the same factor in 8 of 11 analyses
[38,40-44]. Thus, the most prevalent finding was one sin-
gle factor explaining the variance of a mixture of cogni-
tive and somatic symptoms (s1, s2, s5b, and s6).
Figure 4 shows the diversity in the retrieved factors, such
as the number, the item content, and loadings. Figure 5
was derived from Figure 4, and shows the proportion of
pairwise common factor loadings. In total, the studies
described 461 measurements of pairs of symptoms (for
example, the combination of s1 and s2 was measured in all
13 studies, while the combination of s1 and s5a was mea-
sured in 7 studies). Of these 461 measurements of symp-
tom pairs, 97 pairs loaded on a common factor, resulting
in an average proportion of pairwise common factor load-
ings of 0.21 (97/461). In Figure 5, the heights of the 45 ver-
tical bars depend on the proportion of each pair of
symptoms that loaded on a common factor; for example,
pair s1 and s2 loaded 11 out of 13 times on a common fac-
tor, resulting in a proportion of 0.85 pairwise common fac-
tor loadings. In case of a clear two-factor solution, one
would expect to find a landscape of two areas with high
bars, and one area with low bars. Obviously this is not the
case, and neither can those areas be found by rearranging
the symptom orders on the x- or z-axis. Furthermore, for
relatively many symptom pairs the proportion of common
factor loadings approached the average of 0.21, which is
not consistent with a clear two-factor solution. Of note,
weight gain (s3b) and hypersomnia (s4b) were measured
too infrequently to include in this figure.
Figure 6 was also derived from Figure 4, and shows all
depressive symptom combinations that were found to
load on a common factor. In total, 27 factors had an item
content of 2 or more depressive symptoms. The item
content of those 27 factors was unique in 22 factors; only
5 factors had a non-unique item content, with two symp-
tom combinations occurring more than once (Figure 6).
Influence of different patient samples (same variables)
Several studies analyzed the same questionnaires with
different patient samples: three studies used the HRSD
[37,40,41], two studies the BDI [41,42] and three studies
the MADRS [38,43,44]. The analyses of the same ques-
tionnaires resulted in substantial different factors, both
qualitatively (item content) and quantitatively (number
Figure 5 Pairwise common factor loadings. The x- and z-axes show disaggregated depres s i v es y m p t o m s ,w h i l et h ey - a x i ss h o w st h e
proportion of pairwise common factor loadings.
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the resulting dimensional structure can be seen from the
collected analyses (Figure 4). First, differences in severity
affected the factorial structure. Galinowski and Lehert
performed two PCA of the MADRS from the same group
of patients at a different timepoint [43]. On day 0, before
antidepressant treatment, three components explained
55.5% of the variance of the MADRS items, whereas after
28 days of antidepressant treatment, one component
explained 66% of the variance. A likely explanation is the
diminished overall severity score on the MADRS (from
35 to 17 points), with a decrease in correlations between
items. However, such severity differences do not explain
all variety in factor structure. This is illustrated by the
studies of Corruble et al. and of Galinowski and Lehert
[43,44], which both had a patient sample with a roughly
similar mean MADRS score (34 vs. 35 points), yet, the
principal components derived from the samples differ
considerably (two versus three PCs, explaining 75% vs.
55.5% of the variance with a different item content).
Similar diverging factor patterns resulted from the stu-
dies analyzing the BDI or HRSD.
Influence of different questionnaires (same patient sample)
Two studies investigated the factor structure of different
questionnaires from the same patient sample in separate
analyses. First, Steer et al. performed two PCA on the BDI
and the HRSD, which resulted in three and seven qualita-
tively different components, respectively [41](Figure 4).
Second, Corruble et al. performed four PCA on the IDS-C,
IDS-SR, MADRS and the SCL-90R [44], and the variety in
the resulting factor structure was again substantial. Even
the two PCA on the IDS Clinician (IDS-C) and IDS Self-
Report (IDS-SR) ratings produced components with a dif-
ferent item content, though the questionnaires are largely
similar.
Combining items of multiple questionnaires in one analysis
Four studies performed latent factor analyses on a
combination of items from different questionnaires
[36,37,41,54]. Although response categories vary between
different questionnaires, no study used a smoothing
method to adjust for these variances, which could explain
part of the following results. Steer et al. performed PCA
on a combination of all HRSD and BDI items. All BDI
items loaded on principal component 1 (PC1), whereas
the HRSD items loaded on PC2 and PC3 [41]. A largely
similar result was found by Uher et al., using EFA on 47
items from the MADRS, the HRSD, and the BDI. The
depressive symptom items of the MADRS and the HRSD
predominantly loaded on factor 1, whereas BDI items
mainly loaded on factor 3 [36]. Thus, those studies show a
high correlation of items in one questionnaire. The oppo-
site result was found by Gullion and Rush [54], who per-
formed EFA on 88 items of the IDS-C, IDS-SR, HRSD,
and BDI. They identified 10 factors mainly explaining the
variance of items measuring the same symptom in the dif-
ferent questionnaires; for example, factor 2 comprised sev-
eral items measuring guilt/worthlessness (s7), for instance
‘guilt feelings’ (BDI), ‘guilt feelings’ (HRSD), ‘self-criticism
and blame’ (IDS-SR, IDS-C).
Ohaeri and Otote performed the fourth analysis in
which items of different questionnaires are included, that
is, items of the HRSD and the BPRS [37]. Of note, these
authors also performed EFA on the HRSD items alone
(Figure 4), therefore, the effect of the extra BPRS items on
the factorial structure is directly observable in this study.
First, EFA of the HRSD items exclusively resulted in four
factors, explaining 43.1% of the variance. The first factor
comprised six items: depressed mood, anhedonia, weight
and appetite loss, psychomotor retardation, and paranoid
symptoms, and this factor is described as ‘core depressive’.
Second, an EFA on the HRSD plus BPRS items also
resulted in four factors, explaining 43.7% of the variance.
The first factor is again described as ‘core depressive’;
however, this factor now contains different items. Of the
previous six HRSD items only two remained: depressed
mood and psychomotor retardation. By contrast, the item
with the highest factor loading was uncooperativeness
(0.8). In addition, the factor contained hypochondriasis,
insight loss, and emotional withdrawal. A comparable shift
in item content was found for the other factors.
1 1 1 1 1 1 
2 
1 1 1 1 1 1 1 
3 
1 1 1 1 1 1 1 1 1 
Figure 6 Frequencies of symptom combinations loading on a common factor. The x-axis shows all symptom combinations loading on a
common factor, while the y-axis shows the number of times this specific common factor has been identified.
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Our results show that studies performed to date provide
insufficient evidence to confirm the stable existence of
clear data-driven symptomatic subtypes of depression.
First, relatively few studies have been dedicated to the
detection of data-driven MDD subtypes (20 of 1176 arti-
cles). Second, the outcomes of these few studies are con-
flicting. Latent class analyses mainly grouped patients on
overall severity, but not in classes with qualitatively differ-
ent symptom profiles, whereas latent factor analyses, most
consistently identified a factor explaining the variance of a
mixture of cognitive and somatic symptoms (s1, s2, s5b,
s6), which seems in contradiction with a purely cognitive
or somatic symptom dimension. However, the 13 identi-
fied factors differed to such an extent that generalizable
conclusions are questionable. In short, the collected stu-
dies fail to give adequate evidence for the existence of qua-
litatively different subtypes or symptom dimensions of
MDD. Thus, this lack of empirical support also holds for
theoretical motivated subtypes such as as melancholic or
atypical, or cognitive and somatic symptom dimensions in
MDD.
Particularly notable is the great deal of diversity in the
results. How can we explain this large diversity? From the
collected results, it can be seen that all sorts of factors
influence the outcomes of latent variable analyses; for
instance, the included number of patients, and the severity
and quantity of their symptoms obviously affect the result-
ing latent classes and factors. Presumably, there is consid-
erable difference in symptom endorsement rates between
the studies, as was reported from a recent mega-analysis
of genome-wide association studies of patients with MDD
[55]. Furthermore, the extensive number and differences
of the questionnaires used, including all not recorded
symptoms (weight gain, hypersomnia), is a likely contribu-
tor to the diverging results. On top of that, previous stu-
dies have found that in case of latent factor analyses,
several items, including model choice (for example, com-
ponent or common factor model), sample size, number
and communalities of the variables, selection of the num-
ber of factors and model fit criteria, rotation method, and
the degree of overdetermination, affect the stability and
correspondence of the resulting factors [56-58]. An extra
influence to take into account is the manifestly high corre-
lation of symptoms within one questionnaire, as shown by
some (not all) latent factor analyses on different question-
naires simultaneously. Thus, many theoretical choices pre-
ceding analysis are important determinants of the
retrieved classes or dimensions.
T h em a j o ri n s i g h tf r o mt h i sr e v i e wi st h a tw es h o u l d
improve our research techniques considerably to find
data-driven subtypes of depression. Of course, it is an
open-ended question as to whether such a pattern exists.
It is possible that there simply are no symptomatic sub-
types or dimensions, and that latent variable techniques
have failed to show consistent subtypes because of this
fact. One could argue that if there were clear symptomatic
subtypes or dimensions, a more consistent pattern would
have emerged out of the data, regardless of the theoretical
and measurement choices involved. The other possibility
is that symptomatic subtypes and dimensions do exist, but
that the techniques used to date did not succeed in identi-
fying them. If the second possibility is true, a crucial ques-
tion is how study methods could be improved to detect
patterns in the data that have not yet been detected.
Careful consideration of all theoretical and modeling
choices that influence study outcomes will be required to
answer that question.
One possible strategy to improve study methods is data
enrichment, because it is clear that the quality of data cru-
cially determines the quality of study outcomes. First,
some of the studies reviewed above indicate the possible
benefit of dynamic measurements, as they showed that dif-
ferentiated symptom profiles might be clearer with more
rather than less severe cases or for patients earlier rather
than later in the treatment process. Therefore it would
seem prudent to study changes in symptom structure and
severity over the course of treatment, preferably also dis-
tinguishing the influence of medication. A second set of
choices would involve the scales used to assess these
symptoms. Some diagnostic instruments use dichotomous
(yes/no) measures for each symptom, whereas others have
gradual assessments. Gradual assessments, would of
course be expected to provide textured differentiation, and
in this way possibly lead to greater precision in detecting
meaningful subtypes. Another concern is that the fre-
quently used rating scales are primarily designed to be
sensitive to change as opposed to capturing the detailed
phenomenological picture of MDD. To address the poten-
tial heterogeneity in patients with depression, at least all
DSM criteria, including all disaggregated symptoms (s3-
s5), should be measured in a standardized fashion. A third
possibility to enrich data would be the inclusion of other
variables in addition to depressive symptoms in analyses.
Concerning the symptoms to include in the evaluation, it
seems clear that this set of symptoms should be a broad
one, so as to allow for the possibility of detecting subtypes
associated with symptoms beyond those in the current
DSM and ICD systems. For example, there is some sug-
gestion in the literature that there might be value in differ-
entiating irritable from non-irritable MDD [59] and in
assessing the influence of anxiety [60,61]. Moreover, apart
from symptoms, other indicators, such as hormone status,
genetic profile, sex, and age, could also be included as
variables in future analyses. The inclusion of these
non-symptomatic variables possibly contributes to the
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although we firmly believe that symptoms are the basis on
which to start. Symptoms are non-invasive measures of
disease; clinicians are trained to recognize and classify
patients based on symptoms; and data on symptoms have
been collected world-wide.
A second strategy to improve study methods involves
the statistical approaches used to uncover depressive
dimensions and subtypes. In addition to the latent factor
and latent class approaches, we should consider complex
CA models, especially those that use a canonical formu-
lation to predict diverse outcomes [62,63], and mixture
models that combine features of latent class and item
response theory models [64] or latent class and latent
factor models [14]. Some recent studies have used factor
mixture analyses to identify subtypes in other psychiatric
disorders, such as attention-deficit/hyperactivity disorder
[65], post-traumatic stress disorder [13], and schizophre-
nia [66]. To date, these approaches have not yet been
used to search for subtypes of MDD, but are attractive
alternatives in light of their success in detecting useful
subtypes of other disorders. Obviously, in accordance
with the described latent variable models, many theore-
tical factors should be considered before applying those
new techniques [67]. However, if subtypes of MDD do
exist, using different statistical methods to reveal their
structure could be worthwhile.
Thus, future analyses should ideally explore several
advanced statistical techniques on enriched datasets. An
investigation of the possibilities and limitations of differ-
ent modeling techniques seems more reasonable than
adhering exclusively to the latent factor and latent class
models used up to now. Mega-analyses of the MDD
symptoms of different samples could be worthwhile, as
combined data may have a positive effect on robustness
and generalizability of the results [55,68]. However,
when performing mega-analyses, it is even more impor-
tant to have rich datasets and to apply sophisticated
modeling techniques to the data to accommodate inter-
study heterogeneity [55]. Experiences with those new
symptom-based classification attempts might inform
other data-driven classification attempts that go beyond
the DSM, such as the Research Domain Criteria [69,70].
Finally, what is the value of searching for data-driven
subtypes of MDD? We started our review with the
observation that patients with MDD differ considerably
in their symptomatic presentation, with over 200 possi-
ble symptom combinations. To date, theoretical moti-
vated subtypes have not resolved the substantial
population heterogeneity of MDD. Empirical discern-
ment of subtypes with similar symptoms could give an
impetus to research on etiology, course, and treatment.
Improved statistical tools are available to discover
patterns in rich datasets, therefore, data-driven subtyp-
ing of depression is a valuable approach to be explored.
Conclusions
T h e r ei sn oc o n c l u s i v ee v i d e n c ef o rt h ee x i s t e n c eo f
depressive symptom dimensions or symptomatic sub-
types in adults with MDD. Many theoretical and model-
ing choices affect the results of latent variable analyses.
If there is any structure to be discovered in the current
heterogeneity, consideration of those choices would pro-
vide an useful starting point for future studies.
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